Global Wearable Ultrasound Devices Market Strategic Research Report 2026-2031

1.1.1 Market Definition and Headline Sizing
1.1.2 Key Growth Drivers
1.1.3 Segmentation Highlights
1.1.4 Regional and Country Highlights
1.1.5 Competitive Structure
1.1.6 Principal Risks and Restraints
1.1.7 Outlook

2.1 Market Definition and Scope
2.2 Market Size and Historical Performance
2.3 Forecast and Growth Logic
2.4 Volume Analysis
2.5 Value-Chain and Pricing Architecture

3.1 Overview of the Type Segmentation Framework
3.1.1 Bone Healing Ultrasound
3.1.2 Pain and Soft-Tissue Therapy
3.1.3 Monitoring and Diagnostic Patches
3.2 Volume Analysis
3.2.1 Global Unit Volume by Year, 2022-2031
3.3 Comparative Commentary on Revenue Mix Shift

4.1 Overview of the Application Segmentation Framework
4.1.1 Home Healthcare
4.1.2 Hospital and Critical Care
4.1.3 Clinics, Rehabilitation and Sports Medicine
4.1.4 Comparative Assessment of Application Segments

5.1 North America
5.1.1 Regional Overview
5.1.2 Key Growth Drivers
5.1.3 Regulatory & Infrastructure Landscape
5.1.4 Country-Level Analysis
5.1.5 Market Forecast 2025-2031
5.2 Europe
5.2.1 Regional Overview
5.2.2 Key Growth Drivers
5.2.3 Regulatory & Infrastructure Landscape
5.2.4 Country-Level Analysis
5.2.5 Market Forecast 2025-2031
5.3 Asia Pacific
5.3.1 Regional Overview
5.3.2 Key Growth Drivers
5.3.3 Regulatory & Infrastructure Landscape
5.3.4 Country-Level Analysis
5.3.5 Market Forecast 2025-2031
5.4 Latin America
5.4.1 Regional Overview
5.4.2 Key Growth Drivers
5.4.3 Regulatory & Infrastructure Landscape
5.4.4 Country-Level Analysis
5.4.5 Market Forecast 2025-2031
5.5 Middle East and Africa
5.5.1 Regional Overview
5.5.2 Key Growth Drivers
5.5.3 Regulatory & Infrastructure Landscape
5.5.4 Country-Level Analysis
5.5.5 Market Forecast 2025-2031

6.1 North America
6.1.1 United States
6.1.2 Canada
6.1.3 Mexico
6.1.4 Rest of North America
6.2 Europe
6.2.1 Germany
6.2.2 United Kingdom
6.2.3 France
6.2.4 Italy
6.2.5 Spain
6.2.6 Netherlands
6.2.7 Rest of Europe
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 South Korea
6.3.4 Australia
6.3.5 India
6.3.6 Singapore
6.3.7 Rest of Asia Pacific
6.4 Latin America
6.4.1 Brazil
6.4.2 Argentina
6.4.3 Chile
6.4.4 Colombia
6.4.5 Rest of Latin America
6.5 Middle East and Africa
6.5.1 Saudi Arabia
6.5.2 United Arab Emirates
6.5.3 Turkey
6.5.4 Israel
6.5.5 South Africa
6.5.6 Rest of Middle East and Africa

7.1 Section Overview
7.2 Market Growth Drivers
7.2.1 Proven Clinical Efficacy of Low-Intensity Pulsed Ultrasound in Fracture Healing Sustains
7.2.2 Accelerating Technology Maturation in Flexible Transducer Engineering Enables New
7.2.3 Expanding Home Healthcare Infrastructure and Shift Toward Ambulatory Treatment
7.2.4 Clinical Validation Momentum in Haemodynamic Monitoring Patches Signals Imminent
7.2.5 Government and Defence Funding Reduces Early-Stage Capital Risk and Validates
7.2.6 Regulatory Pathway Expansion and Jurisdictional Diversification Broaden Market Access
7.3 Market Restraints
7.3.1 Extremely Limited Number of Revenue-Generating Commercial Products Constrains
7.3.2 Reimbursement Coverage Remains Narrow, Restricting Uptake Beyond Established
7.3.3 Proposed FDA Down-Classification of Bone Growth Stimulators Creates Pricing and
7.3.4 Extended Clinical Validation Timelines and Flexible Transducer Reliability Constraints
7.3.5 Data Integrity Gaps and Unverified Commercial Claims Impede Investor Confidence and
7.4 Driver and Restraint Impact Assessment
7.5 Integrated Assessment

8.1 Bioventus Inc.
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023-2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2025-2031)
8.2 Orthofix Medical Inc.
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023-2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2025-2031)
8.3 ZetrOZ Systems
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023-2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2025-2031)
8.4 Flosonics Medical
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023-2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2025-2031)
8.5 IGEA S.p.A.
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023-2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2025-2031)
8.6 UNIO Medical Devices Inc.
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023-2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2025-2031)
8.7 iSono Health
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023-2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2025-2031)
8.8 Sonus Microsystems
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023-2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2025-2031)
8.9 Novosound
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023-2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2025-2031)
8.10 Softsonics
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023-2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2025-2031)
8.11 ClearSens, Inc.
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023-2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2025-2031)
8.12 Pulsenmore Ltd.
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023-2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2025-2031)

9.1 Competitive Landscape Overview
9.1.1 Market Structure and Industry Configuration
9.1.2 Company Reference Table
9.1.3 Why Market Concentration Cannot Be Measured
9.1.4 Competitive Dynamics by Segment
9.1.5 Competitive Intensity Assessment
9.2 Competitive Intensity Assessment
9.2.1 Structural Grouping of the Competitive Field
9.2.2 Capacity Versus Demand Dynamics
9.2.3 Pricing Environment
9.2.4 Barriers to Entry and Exit
9.3 Key Player Strategies & Positioning
9.3.1 Strategic Group Landscape
9.3.2 Bioventus Inc. - Defending the Revenue Base Through Organic Growth and Channel
9.3.3 Orthofix Medical Inc. - Gaining Ground Through PMA Approval and Segment Scale
9.3.4 ZetrOZ Systems - Penetrating the Military, Veterans, and Sports Medicine Niches
9.3.5 Flosonics Medical - Pivoting from Clinical Utility to Government-Backed Scale
9.3.6 IGEA S.p.A. and UNIO Medical Devices - European and Canadian Regulatory
9.3.7 Emerging Innovators - Technology Differentiation as the Primary Competitive Lever
9.3.8 Summary Competitive Intelligence Table
9.3.9 R&D and Technology Investment Trends
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 The Current Competitive Structure
9.4.2 Emerging Competitive Threats
9.4.3 Consolidation vs. Fragmentation Outlook
9.4.4 Competitive Response Matrix
9.4.5 Strategic Recommendations for 2025-2031

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11.1 Political
11.2 Economic
11.3 Sociocultural
11.4 Technological
11.5 Legal
11.6 Environmental
11.7 PESTLE Summary Assessment Table

12.1 Industry SWOT Analysis
12.1.1 Detailed Analysis
12.1.1.1 Strengths
12.1.1.2 Weaknesses
12.1.1.3 Opportunities
12.1.1.4 Threats
12.1.2 Strategic Implications

13.1 Overview
13.2 Trend Analyses
13.2.1 Transition from Single-Transducer Therapy to Multi-Transducer Array Patch
13.2.2 Artificial Intelligence Integration for Real-Time Signal Interpretation and Clinical
13.2.3 Regulatory Pathway Maturation and Reclassification Dynamics
13.2.4 Expansion of Government and Defense Procurement as a Market Development Catalyst
13.2.5 Emergence of Continuous Haemodynamic Monitoring as the Dominant Growth
13.2.6 Ultrasound-as-a-Service and Subscription Revenue Model Adoption
13.2.7 Geographic Expansion Beyond North American Core Market
13.2.8 Maternal and Fetal Health as an Emerging High-Acuity Application Vertical
13.3 Summary of Trends
13.4 Forward Outlook: 2026-2031

Exhibit 2.1: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.2: Forecast of Global Market YoY Growth Rate & CAGR Summary (in %)
Exhibit 2.3: Forecast of Global (in USD Mn)
Exhibit 2.4: Forecast of North America (in USD Mn)
Exhibit 2.5: Forecast of Europe (in USD Mn)
Exhibit 2.6: Forecast of Asia Pacific (in USD Mn)
Exhibit 2.7: Forecast of Latin America (in USD Mn)
Exhibit 2.8: Forecast of Middle East and Africa (in USD Mn)
Exhibit 2.9: Forecast of Global (in K Units)
Exhibit 2.10: Forecast of North America (in K Units)
Exhibit 2.11: Forecast of Europe (in K Units)
Exhibit 2.12: Forecast of Asia Pacific (in K Units)
Exhibit 2.13: Forecast of Latin America (in K Units)
Exhibit 2.14: Forecast of Middle East and Africa (in K Units)
Exhibit 3.15: Forecast of Bone Healing Ultrasound (in USD Mn)
Exhibit 3.16: Forecast of Bone Healing Ultrasound (in K Units)
Exhibit 3.17: Forecast of Pain and Soft-Tissue Therapy (in USD Mn)
Exhibit 3.18: Forecast of Pain and Soft-Tissue Therapy (in K Units)
Exhibit 3.19: Forecast of Monitoring and Diagnostic Patches (in USD Mn)
Exhibit 3.20: Forecast of Monitoring and Diagnostic Patches (in K Units)
Exhibit 4.21: Forecast of Home Healthcare (in USD Mn)
Exhibit 4.22: Forecast of Home Healthcare (in K Units)
Exhibit 4.23: Forecast of Hospital and Critical Care (in USD Mn)
Exhibit 4.24: Forecast of Hospital and Critical Care (in K Units)
Exhibit 4.25: Forecast of Clinics, Rehabilitation and Sports Medicine (in USD Mn)
Exhibit 4.26: Forecast of Clinics, Rehabilitation and Sports Medicine (in K Units)
Exhibit 6.27: Forecast of North America (in USD Mn)
Exhibit 6.28: Forecast of United States (in USD Mn)
Exhibit 6.29: Forecast of Canada (in USD Mn)
Exhibit 6.30: Forecast of Mexico (in USD Mn)
Exhibit 6.31: Forecast of Rest of North America (in USD Mn)
Exhibit 6.32: Forecast of North America (in K Units)
Exhibit 6.33: Forecast of United States (in K Units)
Exhibit 6.34: Forecast of Canada (in K Units)
Exhibit 6.35: Forecast of Mexico (in K Units)
Exhibit 6.36: Forecast of Rest of North America (in K Units)
Exhibit 6.37: Forecast of Europe (in USD Mn)
Exhibit 6.38: Forecast of Germany (in USD Mn)
Exhibit 6.39: Forecast of United Kingdom (in USD Mn)
Exhibit 6.40: Forecast of France (in USD Mn)
Exhibit 6.41: Forecast of Italy (in USD Mn)
Exhibit 6.42: Forecast of Spain (in USD Mn)
Exhibit 6.43: Forecast of Netherlands (in USD Mn)
Exhibit 6.44: Forecast of Rest of Europe (in USD Mn)
Exhibit 6.45: Forecast of Europe (in K Units)
Exhibit 6.46: Forecast of Germany (in K Units)
Exhibit 6.47: Forecast of United Kingdom (in K Units)
Exhibit 6.48: Forecast of France (in K Units)
Exhibit 6.49: Forecast of Italy (in K Units)
Exhibit 6.50: Forecast of Spain (in K Units)
Exhibit 6.51: Forecast of Netherlands (in K Units)
Exhibit 6.52: Forecast of Rest of Europe (in K Units)
Exhibit 6.53: Forecast of Asia Pacific (in USD Mn)
Exhibit 6.54: Forecast of Japan (in USD Mn)
Exhibit 6.55: Forecast of China (in USD Mn)
Exhibit 6.56: Forecast of South Korea (in USD Mn)
Exhibit 6.57: Forecast of Australia (in USD Mn)
Exhibit 6.58: Forecast of India (in USD Mn)
Exhibit 6.59: Forecast of Singapore (in USD Mn)
Exhibit 6.60: Forecast of Rest of Asia Pacific (in USD Mn)
Exhibit 6.61: Forecast of Asia Pacific (in K Units)
Exhibit 6.62: Forecast of Japan (in K Units)
Exhibit 6.63: Forecast of China (in K Units)
Exhibit 6.64: Forecast of South Korea (in K Units)
Exhibit 6.65: Forecast of Australia (in K Units)
Exhibit 6.66: Forecast of India (in K Units)
Exhibit 6.67: Forecast of Singapore (in K Units)
Exhibit 6.68: Forecast of Rest of Asia Pacific (in K Units)
Exhibit 6.69: Forecast of Latin America (in USD Mn)
Exhibit 6.70: Forecast of Brazil (in USD Mn)
Exhibit 6.71: Forecast of Argentina (in USD Mn)
Exhibit 6.72: Forecast of Chile (in USD Mn)
Exhibit 6.73: Forecast of Colombia (in USD Mn)
Exhibit 6.74: Forecast of Rest of Latin America (in USD Mn)
Exhibit 6.75: Forecast of Latin America (in K Units)
Exhibit 6.76: Forecast of Brazil (in K Units)
Exhibit 6.77: Forecast of Argentina (in K Units)
Exhibit 6.78: Forecast of Chile (in K Units)
Exhibit 6.79: Forecast of Colombia (in K Units)
Exhibit 6.80: Forecast of Rest of Latin America (in K Units)
Exhibit 6.81: Forecast of Middle East and Africa (in USD Mn)
Exhibit 6.82: Forecast of Saudi Arabia (in USD Mn)
Exhibit 6.83: Forecast of United Arab Emirates (in USD Mn)
Exhibit 6.84: Forecast of Turkey (in USD Mn)
Exhibit 6.85: Forecast of Israel (in USD Mn)
Exhibit 6.86: Forecast of South Africa (in USD Mn)
Exhibit 6.87: Forecast of Rest of Middle East and Africa (in USD Mn)
Exhibit 6.88: Forecast of Middle East and Africa (in K Units)
Exhibit 6.89: Forecast of Saudi Arabia (in K Units)
Exhibit 6.90: Forecast of United Arab Emirates (in K Units)
Exhibit 6.91: Forecast of Turkey (in K Units)
Exhibit 6.92: Forecast of Israel (in K Units)
Exhibit 6.93: Forecast of South Africa (in K Units)
Exhibit 6.94: Forecast of Rest of Middle East and Africa (in K Units)